en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
 
4/2022
vol. 124
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł oryginalny

Episcleral brachytherapy for intraocular retinoblastoma with 106Ruthenium plaque: analysis of 13 procedures

Krzysztof Cieślik
1
,
Anna Rogowska
1
,
Małgorzata Danowska
1
,
Karolina Trocka
1
,
Olga Rutynowska
2
,
Bożenna Dembowska-Bagińska
2
,
Agnieszka Kołodziejczyk-Gietka
2
,
Ingeborga Charzyńska
3
,
Wojciech Hautz
1

1.
Department of Ophthalmology, Children’s Memorial Health Institute in Warsaw, Poland
2.
Department of Oncology, Children’s Memorial Health Institute in Warsaw, Poland
3.
Department of Nuclear Medicine, Children’s Memorial Health Institute in Warsaw, Poland
KLINIKA OCZNA 2022, 124, 4: 211-215
Data publikacji online: 2022/01/05
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Metryki PlumX:
Aim of the study
Aim of the study: To evaluate the efficacy of 106Ru episcleral brachytherapy for the treatment of retinoblastoma.

Material and methods
Retrospective series of all 13 children with retinoblastoma treated with 106Ru plaques at the Department of Ophthalmology of the Children’s Memorial Health Institute in Warsaw between 01.01.2015 and 31.12.2020.

Results
A total of 13 tumors were treated with 106Ru brachytherapy. In all cases it was a salvage treatment for tumors resistant to other treatment modalities, after a mean of 3.15 relapses. Overall tumor control was achieved in 12 cases (92.3%). Tumor recurrence was observed in 1 case (7.7%) which led to enucleation. Radiation complications included persistent hemorrhages from neovascularization in 4 cases (30.8%).

Conclusions
106Ru brachytherapy can be an effective salvage treatment for retinoblastoma.



Aim of the study
To evaluate the efficacy of 106Ru episcleral brachytherapy for the treatment of retinoblastoma.

Material and methods
Retrospective series of all 13 children with retinoblastoma treated with 106Ru plaques at the Department of Ophthalmology of the Children’s Memorial Health Institute in Warsaw between 01.01.2015 and 31.12.2020.

Results
A total of 13 tumors were treated with 106Ru brachytherapy. In all cases it was a salvage treatment for tumors resistant to other treatment modalities, after a mean of 3.15 relapses. Overall tumor control was achieved in 12 cases (92.3%). Tumor recurrence was observed in 1 case (7.7%) which led to enucleation. Radiation complications included persistent hemorrhages from neovascularization in 4 cases (30.8%).

Conclusions
106Ru brachytherapy can be an effective salvage treatment for retinoblastoma.

słowa kluczowe:

episcleral brachytherapy, plaque radiotherapy, retinoblastoma, ruthenium

facebook linkedin twitter
© 2023 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.